These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8974380)

  • 1. Pharmacotherapy in alcoholism treatment: integrating and understanding the use of serotonin reuptake inhibitors.
    George FR
    Alcohol Alcohol Suppl; 1994; 2():537-43. PubMed ID: 8974380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():69-75. PubMed ID: 8737004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.
    Naranjo CA; Knoke DM
    J Clin Psychiatry; 2001; 62 Suppl 20():18-25. PubMed ID: 11584871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption.
    Naranjo CA; Bremner KE
    Alcohol Alcohol Suppl; 1993; 2():221-9. PubMed ID: 7748304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data.
    Lê AD; Tomkins DM; Sellers EM
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():27-32. PubMed ID: 8736998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin's Complex Role in Alcoholism: Implications for Treatment and Future Research.
    Marcinkiewcz CA; Lowery-Gionta EG; Kash TL
    Alcohol Clin Exp Res; 2016 Jun; 40(6):1192-201. PubMed ID: 27161942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-altering medications and desire, consumption and effects of alcohol-treatment implications.
    Naranjo CA; Bremner KE
    EXS; 1994; 71():209-19. PubMed ID: 8032152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):69-75. PubMed ID: 9845041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes.
    Pettinati HM
    J Clin Psychiatry; 2001; 62 Suppl 20():26-31. PubMed ID: 11584872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current pharmacotherapies of alcoholism: a U.S. perspective.
    Anton RF; Swift RM
    Am J Addict; 2003; 12(s1):s53-s68. PubMed ID: 14972780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of the central serotonin system on alcoholism and therapeutic consequences].
    Peter H; Bandelow B; Krausz M
    Fortschr Neurol Psychiatr; 1998 Oct; 66(10):459-65. PubMed ID: 9825251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data.
    Lê AD; Tomkins DM; Sellers EM
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):27-32. PubMed ID: 9845035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biobehavioural basis of pharmacologic treatment of alcohol dependence.
    Sellers EM
    Alcohol Alcohol Suppl; 1994; 2():517-21. PubMed ID: 8974377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety and alcoholism: a serotonin link.
    Tollefson GD
    Br J Psychiatry Suppl; 1991 Sep; (12):34-9. PubMed ID: 1840761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence.
    Pettinati HM; Kranzler HR; Madaras J
    Recent Dev Alcohol; 2003; 16():247-62. PubMed ID: 12638641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date.
    Lee MR; Leggio L
    CNS Drugs; 2014 Feb; 28(2):107-19. PubMed ID: 24497006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion, a possible antidepressant without negative effects on alcohol relapse.
    Ballesta A; Orio L; Arco R; Vargas A; Romero-Sanchiz P; Nogueira-Arjona R; de Heras RG; Antón M; Ramírez-López M; Serrano A; Pavón FJ; de Fonseca FR; Suárez J; Alen F
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):756-765. PubMed ID: 31064683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SSRI antidepressants and alcoholism].
    Rossinfosse C; Wauthy J; Bertrand J
    Rev Med Liege; 2000 Nov; 55(11):1003-10. PubMed ID: 11195702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.
    Johnson BA
    CNS Drugs; 2004; 18(15):1105-18. PubMed ID: 15581381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.
    Meert TF
    Alcohol Alcohol; 1993 Mar; 28(2):157-70. PubMed ID: 8517886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.